(1)
Sadikova N.G; Najmutdinova D. K; Urunbayeva D. A; Alimova S. E; Tillaboyev Sh.Sh. Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Gen. Rep. 2023, 26, 1-4.